Papyrus Therapeutics

Papyrus Therapeutics is an emerging biopharmaceutical company dedicated to developing novel therapies based on tumor suppression. Papyrus' lead therapeutic is a modified recombinant version of opioid-binding protein/cell adhesion molecule-like (OPCML).